The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Driscoll Frederick W since year 2005.
The trader's CIK number is 1129890.
At the time of this reporting, Driscoll Frederick W is the Chief Financial Officer of Flexion Therapeutics Inc .
(stock ticker symbol FLXN).
See this page for all insider trading activities at Flexion Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-03-23||FLXN||Flexion Therapeutics Inc||Sale||3,000||23.00||69,000|
|2017-03-23||FLXN||Flexion Therapeutics Inc||Option Ex||3,000||7.89||23,658|
|2017-02-28||FLXN||Flexion Therapeutics Inc||Sale||33,434||20.19||674,999|
|2017-02-28||FLXN||Flexion Therapeutics Inc||Option Ex||30,000||7.89||236,580|
|2016-05-17||FLXN||Flexion Therapeutics Inc||Buy||2,500||9.87||24,667|
|2016-05-16||FLXN||Flexion Therapeutics Inc||Buy||2,500||9.19||22,972|
|2007-11-28||GNLB||Genelabs Technologies Inc /ca||Buy||6,890||1.45||9,990|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Driscoll Frederick W (Chief Financial Officer of Flexion Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.